A phase 3 study of androgen annihilation in high-risk biochemically relapsed prostate cancer.

Skip to Content

Clinical Trial Details

Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

A phase 3 study of androgen annihilation in high-risk biochemically relapsed prostate cancer.

Objective

Visit the National Cancer Institute's Web Site.

IRB Protocol Number
AFT-19

Clinical Trial Categories

  • Prostate Cancer
Contact
NH Oncology Hematology Clinical Research Dept. at 603-224-2556

Location

  • Payson Center for Cancer Care
    250 Pleasant Street
    Concord, NH 03301
    Main: 603-230-6000